×
0 -0.0202020202020201 -0.0202020202020201 0.0101010101010101 0.0545454545454546 0.0525252525252525 0.0686868686868687 0.0222222222222223
Stockreport

Bellicum's cancer drug trials on clinical hold, shares tumble [Reuters]

BELLICUM PHARMACEUTICALS (BLCM)  More Company Research Source: Reuters
Last bellicum pharmaceuticals earnings: 8/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bellicum.com/investor-overview
PDF Bellicum's cancer drug trials on clinical hold, shares tumble | Reuters Reuters Staff 1 Min Read Jan 30 (Reuters) - Bellicum Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a clinical hold on U.S. trials of the company’s experimental cancer drug after three cases of brain disease linked to head trauma. Shares of the Houston-based drug developer fell 48 percent to $5.26 in after-hours trading on Tuesday. The company said the FDA had deemed the cases of brain disease as possibly being related to its cancer drug, BPX-501. Bellicum said it would work closely with the FDA to address concerns. The clinical hold does not affect another trial testing the same drug in Europe. The company last year moved its planned submission of a European marketing application for the drug to 2019 from a previous expectation of mid-2018. (Reporting by Akankshita; Editing by Sai Sachin Ravikumar) All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges [Read more]

IMPACT SNAPSHOT EVENT TIME: BLCM
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS